MedTrace Logo

Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy

NCT04591847 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-13

No results posted yet for this study

Summary

To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo

Conditions

  • Pregnancy Outcome Among Vitamin D Supplementation During Pregnancy

Interventions

DRUG

Vitamin D 2

Vitamin D2 20000IU 1 tab oral weekly

DRUG

Placebo drug

Placebo drugs 1 tab oral weekly

Sponsors & Collaborators

  • Department of Medical Services Ministry of Public Health of Thailand

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2021-07-31
Completion
2021-08-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04591847 on ClinicalTrials.gov